Biomm

BIOM3.SA

Tags: BR Healthcare Biotechnology

Biomm S.A. Price (BIOM3.SA)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

83,213,000

(10.2659)%

Market Cap of Biomm (BIOM3.SA)

Market cap:

As of , BIOM3.SA has a market cap of . This makes BIOM3.SA the 188th most valuable company in the BR by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Biomm S.A. operates as a biotechnology company in Brazil. It offers AFREZZA, a human insulin inhalation powder; CONFORT CARE, a moisturizing foot cream; GLARGILIN, a glargine insulin; and HERZUMA, a trastuzumab. Biomm S.A. was founded in 2001 and is based in São Paulo, Brazil. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $6.84-21.2
Market Cap 1.28B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. Heraldo Carvalho Marchezini
IPO Date: January, 11, 2000
Country: BR
Currency: BRL
Headquaters: São Paulo, SP
Employees: 130

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: